Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study.

ABSTRACT:

Introduction

Remote electrical neuromodulation (REN) is an acute treatment of migraine. The results from several studies in patients with episodic migraine suggest that REN is an effective and safe acute treatment of migraine. A recent pilot study provided initial support that REN is effective in patients with chronic migraine as well.

Objectives

The current study aimed to validate and provide further evidence for the safety and efficacy of REN in a large sample of patients impacted by chronic migraine.

Methods

In this open-label, single-arm study, patients with chronic migraine treated their headaches with the REN device (Nerivio, Theranica Bio-Electronics Ltd, Israel) for 4 weeks. Participants used an electronic diary to record their symptoms at treatment initiation

SUBMITTER: Grosberg B 

PROVIDER: S-EPMC8519197 | biostudies-literature | 2021 Nov-Dec

REPOSITORIES: biostudies-literature